期刊文献+

法洛四联症根治术后肺动脉瓣置换术研究进展 被引量:2

Recent advances of pulmonary valve replacement after repairing tetralogy of Fallot
原文传递
导出
摘要 随着法洛四联症(tetralogy of Fallot,TOF)手术方法越来越成熟,TOF患儿存活率得到较大提升,然而TOF术后的远期并发症成为影响预后的重要因素,其中最常见的为肺动脉瓣反流(pulmonary regurgitation,PR),可以导致右心室功能不全、运动耐力下降以及心律失常,甚至猝死。肺动脉瓣置换术(pulmonary valve replacement,PVR)是治疗PR的有效手段,手术方式包括传统外科肺动脉瓣置换术(surgical pulmonary valve replacement,SPVR)、经皮肺动脉瓣置换术(percutaneous pulmonary valve replacement,PPVR)及镶嵌治疗。对于肺动脉瓣的替代物,生物瓣膜仍然为大多数医生的首要选择,随着抗凝方案的完善,机械瓣膜也有其特定的适应人群,PVR术后的抗凝方案也不尽一致。现对TOF根治术后PVR的手术指征、肺动脉瓣替代物的选择与术后抗凝方案以及临床治疗进展进行综述。 With constant refining of surgical methods for tetralogy of Fallot(TOF),the survival rate of TOF children has greatly improved.However,the long-term postoperative complications of TOF have become important prognostic factors.The most common complication of pulmonary regurgitation(PR)may lead to right ventricular dysfunction,exercise intolerance,arrhythmia and even sudden death.As an effective treatment for PR,pulmonary valve replacement(PVR)includes surgical pulmonary valve replacement(SPVR),percutaneous pulmonary valve replacement(PPVR)and hybrid therapy.Bioprosthetic valve has remained a primary choice of substituting pulmonary valve.With the improvements of anticoagulation regimens,mechanical valve has its own applicable population and anticoagulation regimens after PVR are also inconsistent.This article reviews the indications of pulmonary valve replacement after radical TOF operations,selecting pulmonary valve replacements,anticoagulant regimens after radical TOF operations and clinical therapeutic advances.
作者 陈峰 李红梅 沈立 Chen Feng;Li Hongmei;Shen Li(Department of Cardiothrocic Surgery,Shanghai Children's Hospital,Shanghai Jiao Tong University,Shanghai 200062,China)
出处 《中华小儿外科杂志》 CSCD 北大核心 2020年第1期88-92,共5页 Chinese Journal of Pediatric Surgery
基金 国家自然科学基金(81371449)。
关键词 肺动脉瓣闭锁不全 法洛四联症 肺动脉瓣置换术 研究进展 Pulmonary Valve Insufficiency Tetralogy of Fallot Pulmonary valve replacement Research progress
  • 相关文献

参考文献1

二级参考文献1

  • 1董力,石应康,许建屏,张尔永,刘金成,李亚雄,倪一鸣,杨谦,韩涛,付博,陈进,任莉,魏蜀亮,陈灏,柳克祥,于风旭,刘建实,肖明第,吴树明,张凯伦,黄焕雷,蒋树林,乔晨辉,王春生,徐志云,周新民,王东进,倪立新,肖颖彬,姜胜利,张桂敏,梁贵友,杨思远,伯平,钟前进,张进宝,张希,朱亚彬,滕晓,朱鹏,黄烽,肖亦敏,曹广庆,田海,夏利民,陆方林,刘寅强,刘达兴,徐航,袁烨,李明,常超,邬晓臣,许哲,郭平,白阳静,薛卫斌,蒋小英,那竹惠,曾秋芸,蔡红,王亚莉,熊锐,金素,郑晓梅,吴丹.中国心脏瓣膜术后多中心低强度抗凝治疗注册登记及随访研究[J].中华医学杂志,2016,96(19):1489-1494. 被引量:46

同被引文献12

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部